Development of Ribozyme-Based Gene-Inactivations; The Example of the Hepatitis Delta Virus Ribozyme

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|7|3|205-216

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.7, Iss.3, 2007-06, pp. : 205-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

[General Articles] Ribozyme-Based Gene-Inactivation Systems Require A Fine Comprehension of their Substrate Specificities; the Case of Delta Ribozyme

By  

Current Medicinal Chemistry, Vol. 10, Iss. 23, 2003-12 ,pp. : 2589-2597

Bentham Science Publishers

Access to resources Recommend Favorite

Ribozyme: RNA as an enzyme, but as a therapeutic?

By Burke J.F.   Thomas S.M.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 9, 1998-09 ,pp. : 1093-1097

Informa Healthcare

Access to resources Recommend Favorite

Ribozyme- and Deoxyribozyme-Strategies for Medical Applications

By  

Current Drug Targets, Vol. 5, Iss. 8, 2004-11 ,pp. : 667-681

Bentham Science Publishers

Access to resources Recommend Favorite

New insights into hepatitis B and hepatitis delta virus entry

By Urban Stephan  

Future Virology, Vol. 3, Iss. 3, 2008-05 ,pp. : 253-264

Future Medicine

Access to resources Recommend Favorite

Gene Silencing Nucleic Acids Designed by Scanning Arrays: Anti-EGFR Activity of siRNA, Ribozyme and DNA Enzymes Targeting a Single Hybridization-accessible Region using the Same Delivery System

By Beale Gary   Hollins Andrew J.   Benboubetra Mustapha   Sohail Muhammad   Fox Stephen P.   Benter Ibrahim   Akhtar Saghir  

Journal of Drug Targeting, Vol. 11, Iss. 7, 2003-08 ,pp. : 449-456

Informa Healthcare

Access to resources Recommend Favorite